Pediatric Anthrax Clinical Management

Bradley, John S.; Peacock, Georgina; Krug, Steven E.; Bower, William A.; Cohn, Amanda C.; Meaney-Delman, Dana; Pavia, Andrew T.

doi:10.1542/peds.2014-0563

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Pediatric Anthrax Clinical Management

Published Date:

May 2014

Publisher's site:

http://dx.doi.org/10.1542/peds.2014-0563 New Site Icon

Source:

Pediatrics. 2014; 133(5):e1411-e1436.

[PDF - 585.17 KB]

Details:

Personal Authors:

Bradley, John S. ; Peacock, Georgina ; Krug, Steven E. ; Bower, William A. ; Cohn, Amanda C. ; ... More ▼

Corporate Authors:

AAP COMMITTEE ON INFECTIOUS DISEASES and DISASTER PREPAREDNESS ADVISORY COUNCIL

Keywords:

[+]

Pubmed ID:

24777226

Pubmed Central ID:

PMC4479255

Description:

Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

AVU3/Intramural CDC HHS/United States

Supporting Files:

nihms699373.nxml

text/plain

No Related Documents.

You May Also Like:

Clinical and epidemiologic principles of anthrax.

Personal Author:

Cieslak, Theodore J.; Eitzen, Edward M.;

Published:

1999 Jul-Aug

Source:

Emerg Infect Dis. 5(4):552-555.

File Type:

[PDF - 61.75 KB]
Anthrax

Corporate Author:

Centers for Disease Control and Prevention (U.S.). David J. Sencer CDC Museum.

Published:

10/28/09

Series:

Infectious disease trading cards ; series 1

Description:

Part of series 1 of the CDC Museum set of Infectious disease trading cards, featuring photos and information about some of the infectious diseases that CDC studies. : Anthrax is a serious disease caused by a very small organism made up of one cell. T...

File Type:

[PDF - 98.92 KB]
Chikungunya : clinical management in dengue-endemic areas

Corporate Author:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.).Division of Vector-Borne Diseases.

Published:

May 5, 2014

Description:

Clinical findings -- Chikungunya and dengue -- Clinical and laboratory features of chikungunya virus infections compared with dengue virus infections -- Treatment and clinical management.

File Type:

[PDF - 158.40 KB]
Bartonella quintana Characteristics and Clinical Management

Personal Author:

Foucault, Cédric; Brouqui, Philippe; Raoult, Didier;

Published:

Feb 2006

Source:

Emerg Infect Dis. 12(2):217-223.

Description:

Bartonella quintana, a pathogen that is restricted to human hosts and louse vectors, was first characterized as the agent of trench fever. The disease was described in 1915 on the basis of natural and experimental infections in soldiers. It is now re...

File Type:

[PDF - 293.60 KB]
Anthrax as a Biological Weapon, 2002 - Updated Recommendations for Management

Corporate Author:

Johns Hopkins Center for Civilian Biodefense Strategies

Source:

JAMA : the journal of the American Medical Association. 2002; 287(17):2236-52.

Status:

current

File Type:

[PDF - 369.19 KB]